查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1309032

介入性肿瘤学市场：按手术、癌症类型和最终用户划分 - COVID-19、俄罗斯-乌克兰衝突和高通货膨胀的累积影响 - 2023-2030 年全球预测

Interventional Oncology Market by Procedure, Cancer Type, End-Users - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球介入性肿瘤市场预计将以7.84%的复合年增长率大幅成长，2023年达到50.4336亿美元，到2030年将达到85.6682亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球介入性肿瘤市场至关重要。透过检验业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 介入性肿瘤学的全球市场规模和预测是多少？

2.在预测期内，COVID-19对全球介入性肿瘤学市场的阻碍因素和影响为何？

3. 在预测期内，全球介入性肿瘤学市场需要投资哪些产品/细分市场/应用/领域？

4.全球介入肿瘤市场的竞争策略是什么？

5. 全球介入肿瘤市场的技术趋势和法律规范是什么？

6.全球介入肿瘤市场主要厂商的市占率为何？

7. 哪些型态和策略性措施被认为适合进入全球介入性肿瘤市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 全球癌症发生率不断上升，老年人口迅速增加
      • 增加政府介入肿瘤学的支出
      • 偏好微创手术
    • 抑制因素
      • 缺乏训练有素的肿瘤干预医生
    • 机会
      • 在门诊提供介入性肿瘤学的好处
      • 介入性肿瘤学新技术进展
    • 任务
      • 替代治疗的存在
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章依程序分類的介入性肿瘤学市场

  • 消融
  • 颗粒栓塞
  • 放射治疗

第7章依癌症类型分類的介入性肿瘤学市场

  • 骨转移
  • 乳癌
  • 肾癌
  • 肝癌
  • 肺癌
  • 摄护腺癌

第8章介入肿瘤学市场：依最终用户分类

  • 门诊手术中心
  • 医院
  • 研究和学术机构

第9章美洲介入肿瘤市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太介入肿瘤学市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲介入肿瘤市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-43127F7279CF

The Global Interventional Oncology Market is forecasted to grow significantly, with a projected USD 5,043.36 million in 2023 at a CAGR of 7.84% and expected to reach a staggering USD 8,566.82 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Interventional Oncology Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Interventional Oncology Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Procedure, market is studied across Ablation, Particle Embolization, and Radiation Therapy. The Particle Embolization is projected to witness significant market share during forecast period.

Based on Cancer Type, market is studied across Bone Metastasis, Breast Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, and Prostate Cancer. The Bone Metastasis is projected to witness significant market share during forecast period.

Based on End-Users, market is studied across Ambulatory Surgery Centers, Hospitals, and Research & Academic Institutes. The Ambulatory Surgery Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Interventional Oncology Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Interventional Oncology Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Interventional Oncology Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Interventional Oncology Market?

4. What is the competitive strategic window for opportunities in the Global Interventional Oncology Market?

5. What are the technology trends and regulatory frameworks in the Global Interventional Oncology Market?

6. What is the market share of the leading vendors in the Global Interventional Oncology Market?

7. What modes and strategic moves are considered suitable for entering the Global Interventional Oncology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Interventional Oncology Market, by Procedure, 2022 vs 2030
  • 4.3. Interventional Oncology Market, by Cancer Type, 2022 vs 2030
  • 4.4. Interventional Oncology Market, by End-Users, 2022 vs 2030
  • 4.5. Interventional Oncology Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in incidence of cancer across the globe and surge in geriatric population
      • 5.1.1.2. Increase in government expenditures for interventional oncology
      • 5.1.1.3. Preference for minimally invasive procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Shortage of trained interventional oncologists
    • 5.1.3. Opportunities
      • 5.1.3.1. Benefits of providing interventional oncology in an outpatient setting
      • 5.1.3.2. New technological advancements for interventional oncology
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of alternative therapies
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Interventional Oncology Market, by Procedure

  • 6.1. Introduction
  • 6.2. Ablation
  • 6.3. Particle Embolization
  • 6.4. Radiation Therapy

7. Interventional Oncology Market, by Cancer Type

  • 7.1. Introduction
  • 7.2. Bone Metastasis
  • 7.3. Breast Cancer
  • 7.4. Kidney Cancer
  • 7.5. Liver Cancer
  • 7.6. Lung Cancer
  • 7.7. Prostate Cancer

8. Interventional Oncology Market, by End-Users

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Hospitals
  • 8.4. Research & Academic Institutes

9. Americas Interventional Oncology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Interventional Oncology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Interventional Oncology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. INTERVENTIONAL ONCOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2022 VS 2030 (%)
  • FIGURE 5. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2022 VS 2030 (%)
  • FIGURE 6. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2022 VS 2030 (%)
  • FIGURE 7. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. INTERVENTIONAL ONCOLOGY MARKET DYNAMICS
  • FIGURE 9. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. INTERVENTIONAL ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. INTERVENTIONAL ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. INTERVENTIONAL ONCOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 5. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PARTICLE EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 9. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 16. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 146. INTERVENTIONAL ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 147. INTERVENTIONAL ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 148. INTERVENTIONAL ONCOLOGY MARKET LICENSE & PRICING